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A B S T R A C T
Objective: To verify the efficacy of dexamethasone in the prophylaxis of nausea and vomiting 
in patients submitted to laparoscopic cholecystectomy. 
Methods: This was a systematic review of the literature through the MEDLINE, Embase, and 
LILACS databases. Only controlled and randomized clinical trials comparing dexamethasone 
to placebo in the prophylaxis of nausea and vomiting in patients submitted to laparoscopic 
cholecystectomy were included. 
Results: The results of this review were based on data from 12 controlled and randomized 
clinical trials, totaling 947  patients. The group of patients who received preoperative 
dexamethasone showed lower incidence of nausea (number needed to treat [NNT]  =  7), 
vomiting (NNT = 7), and need for smaller doses of rescue antiemetics (NNT = 6). 
Conclusion: The preoperative infusion of 8  mg of dexamethasone decreases the risk 
of complications in the postoperative period for patients submitted to laparoscopic 
cholecystectomy.
© 2013 Elsevier Editora Ltda. 
Eficácia da dexametasona na profilaxia de náuseas e vômitos 
no pós-operatório de colecistectomia laparoscópica
R E S U M O
Objetivo: Verificar a eficácia da dexametasona na profilaxia de náuseas e vômitos em 
pacientes submetidos à colecistectomia laparoscópica.
Métodos: Revisão sistemática da literatura através das bases de dados MEDLINE, EMBASE 
e LILACS. Foram incluídos apenas ensaios clínicos controlados e randomizados que 
compararam a dexametasona ao placebo na profilaxia de náusea e vômito em pacientes 
submetidos à colecistectomia laparoscópica.
Palavras-chave:
Colecistectomia laparoscópica
Colelitíase
Dexametasona
Náusea e vômito pós-operatório
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Resultados: Os resultados desta revisão basearam-se em dados de 12  ensaios clínicos 
controlados e randomizados, totalizando 947 pacientes. O grupo de pacientes que recebeu 
dexametasona pré-operatória apresentou menor incidência de náusea (NNT = 7), de vômito 
(NNT = 7) e de necessidade de antieméticos de resgate (NNT = 6).
Conclusão: A infusão pré-operatória de 8 mg de dexametasona diminui o risco de complicações 
no pós-operatório de pacientes submetidos à colecistectomia laparoscópica.
© 2013 
Introduction
Laparoscopic cholecystectomy is one of the most frequently 
performed elective surgeries around the world. Despite the fact 
that it is a highly safe procedure, complications such as nausea, 
vomiting, and pain are frequent during the postoperative 
period, and are among the main causes of patient complaints 
and dissatisfaction.1,2 The main risk factors for nausea and 
vomiting are female gender, non-smoking patients, and 
previous history of these problems.3,4
Dexamethasone, a corticosteroid, has well-defined 
antiemetic, anti-inflammatory, and analgesic effects, in 
addition to having few side effects when administered in small 
doses. It is widely used for controlling nausea and vomiting in 
chemotherapy patients.
The objective of this review was to verify the efficacy of 
dexamethasone in the prophylaxis of nausea and vomiting in 
patients submitted to laparoscopic cholecystectomy.
Methods
Selection criteria
Types of studies
Only controlled and randomized clinical trials (Phase III 
studies) that assessed the efficacy of dexamethasone in 
the prevention of postoperative complications in patients 
submitted to laparoscopic cholecystectomy were included.
Participants
Inclusion criteria were patients with benign pathologies of the 
bile ducts submitted to elective laparoscopic cholecystectomy. 
Exclusion criteria were patients with a history of preoperative 
nausea and vomiting, or chronic use of analgesics or 
corticosteroids.
Types of interventions
Patients who received a preoperative infusion of dexa-
methasone, regardless of the moment, were considered part 
of the intervention group. The control group was formed by 
patients who received a preoperative infusion of placebo. 
Studies that associated the corticosteroid to any antiemetic 
drugs during the preoperative period were excluded.
Types of outcomes
The analyzed outcomes were nausea, vomiting, need for 
antiemetic and analgesic drugs, postoperative complications, 
and length of hospital stay. 
Search strategies
The MEDLINE, Embase, and LILACS electronic databases were 
queried until July 2012.
The MEDLINE database was queried through PubMed, using 
the following search strategy: (adrenal cortex hormones OR 
dexamethasone) AND (postoperative nausea and vomiting 
OR nausea OR vomiting) AND (laparoscopic cholecystectomy) 
AND (randomized controlled trial[Publication Type] OR 
(randomized[Title/Abstract]) AND (controlled[Title/Abstract]) 
AND (trial[Title/Abstract]).
In Embase, the following strategy was used: (adrenal cortex 
hormones OR dexamethasone) AND (postoperative nausea 
and vomiting) AND (laparoscopic cholecystectomy) AND 
(randomized controlled trial).
In LILACS, the following strategy was used: (“Colecistectomia 
Laparoscópica”) AND (“Glucocorticoides” OR “Corticoides”) AND 
(“Náusea e Vômito Pós-Operatório” OR “Náusea” OR “Vômito”).
A manual search was also conducted for references from 
the selected studies, in order to find studies that were not 
included in electronic searches.
Quality of the methodology
Quality of the primary studies was assessed through the criteria 
proposed by Jadad et al.,5 which analyze the description of the 
randomization, adequacy of the randomization, description 
of the blinding, adequacy of the blinding, and description of 
loss to follow-up. Only studies with score higher than 3 were 
included in the comprehensive analysis of the review.
Statistical analysis
All data were analyzed based on the intention of treatment; 
patients were analyzed within the groups to which they 
were randomized, regardless of the treatment and protocol 
irregularities.
Effectiveness or harm measurements expressed in absolute 
numbers were analyzed through the absolute risk difference 
(Mantel-Haenszel), adopting a confidence interval of 95%. 
When there was a statistical difference between the groups, 
the number needed to treat (NNT) or the number needed to 
harm (NNH) was calculated.
Inconsistencies among the clinical trials were estimated 
through the Chi-squared test (x2) for heterogeneity, and 
quantified using the I2 test. Values above 50% were deemed 
relevant. 
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A sensitivity analysis was performed, including only studies 
with type II error < 20%.
Results
Fifty six studies were retrieved through the search strategies 
in the three primary databases used. After reading all relevant 
titles and summaries, 15 articles potentially fit for inclusion 
in the review were selected.6-20 Of these, three were excluded 
after a complete reading: the first was excluded because 
it had a Jadad score < 3 and also because it did not present 
sufficient data for the intention-to-treat analysis;16 the second 
study, due to the lack of results in absolute terms;10 the third 
study, for not being described as double-blind, in addition to 
the lack the of the total number of patients who presented the 
outcomes.9 Thus, this review included data from 12 controlled 
and randomized clinical trials, amounting to 947 patients 
(471 in the dexamethasone group and 476 in the placebo group).
Of the included studies, 116,8,11-20 used an 8 mg intravenous 
dose of dexamethasone, while one7 used 5 mg. The infusion 
time ranged from 90 minutes before the beginning of the 
surgery until the anesthesia.
Incidence of nausea and vomiting
The overall incidence of nausea during the postoperative 
period of patients submitted to laparoscopic cholecystectomy 
was 27.9%, of which 94 cases occurred in the dexamethasone 
group and 171 cases occurred in the placebo group. Patients 
who received corticosteroid during the preoperative period 
showed a reduction in the absolute risk of nausea by 16% (95% 
CI: 0.11 to 0.22; p < 0.001; I2 = 20%; NNT = 7) when compared to 
patients who received saline solution (Fig. 1). 
For the incidence of vomiting, patients who received a dose 
of corticosteroid showed reduction in the risk by approximately 
15% (12.3% x 27.5%; 95% CI: 0.10 to 0.20; p < 0.001; I2 = 0%; 
NNT = 7; Fig. 1). 
Need for antiemetic medication
Seven primary studies analyzed the need for antiemetic 
medication in the postoperative period as an outcome.7,8,11,13,17,19,20 
Patients who received corticosteroid needed a smaller dose 
of rescue antiemetic, representing a reduction in the risk 
by approximately 18% (12.8% x 30.6%; 95% CI: 0.12 to 0.23; 
p < 0.001; I2 = 52%; NNT = 6) when compared to the placebo 
group (Fig. 1). 
Removing from the analysis both studies that resulted in 
relative heterogeneity,11,17 the same effect remained (p < 0.001; 
I2 = 0%; NNT = 6). 
Sensitivity analysis
The sensitivity analysis was performed using the statistical 
power found in the primary studies regarding each outcome, 
pursuant to Table 1. Using this tool as a methodological 
criterion, it was verified that the only benefit found with the 
use of the preoperative corticosteroid was the reduction in the 
need for antiemetics (NNT = 4).
The study using a reduced dose of dexamethasone 
(5 mg)7 did not change the comprehensive analysis of the 
review. However, when analyzed separately, no benefit 
regarding the reduction in nausea and vomiting was verified.
Discussion
Laparoscopic surgery drastically reduced the metabolic, 
hormonal, inflammatory, and immune responses related to 
surgical trauma, thus it has become the routine procedure for 
treatment of cholelithiasis. Nonetheless, a high incidence of 
nausea and vomiting, the main reasons for extended hospital 
stays, is reported in the postoperative period.1,2
Nausea and vomiting after a laparoscopic cholecystectomy 
are caused by multiple factors, depending especially 
on intra-abdominal manipulation and formation of 
pneumoperitoneum, which stretches the peritoneum and 
irritates the diaphragm and viscera.7,8
The mechanism by which glucocorticoids may alleviate 
such complications is not fully understood, but the effects 
are probably centrally mediated through inhibition of the 
prostaglandin synthesis and/or inhibition of the release 
of endogenous opioids, serotonergic inhibition in the 
gastrointestinal tract, and decrease in inflammation of the 
surgical site, reducing parasympathetic impulses to the area 
postrema.21-23
Using tools and careful analyses of both quality of the 
methodology and internal and external validity, this review 
showed, through compelling data, the decrease in the risk 
of nausea and vomiting related to the surgery. Factors that 
could potentially generate clinical heterogeneity among 
the studies were assessed. Regarding the population, the 
articles follow the clinical practice, with a predominance 
of women in the fourth and fifth decade of life with low 
Study Incidence 
of nausea
Incidence 
of vomiting
Need for 
antiemetics
Alghanem SM et al., 2010 10.1% 31.8% 13.4%
Bianchin A et al., 2007 27.1% 42.5% *
Bisgaard T et al., 2003 32.5% 51.9% 34.8%
Erhan Yet al., 2008 77.7% 18.1% *
Feo CV et al., 2006 71.0% 71.0% 97.2%
Fujii Y et al., 2010 29.5% 41.3% *
Fukami Y et al, 2009 50.3% 35.2% *
Murphy GS et al., 2011 77.1% 17.9% 38.1%
Nesek-Adam V et al., 2007 54.3% 53.6% 46.6%
Sánchez-Rodriguez PE et al., 
 2010
* * 94.3%
Wang JJ et al., 1999 45.4% 69.1% *
Wang JJ et al., 2002 42.5% 35.9% 68.7%
*This outcome was not evaluated in the study.
Table 1 – Statistical power established in each primary 
study.
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comorbidity index (ASA I-II). Regarding the intervention, 
the confounding factors were: 1) the duration of the surgery 
(approximately 1 hour), which did not present clinically 
significant differences among the studies; 2) the protocols 
of perioperative analgesia; 3) the moment of corticosteroid 
administration, which ranged from 90 minutes before the 
surgery until the anesthetic induction.
Despite the known risks of infection, impairment of 
the surgical wound healing, hyperglycemia, and adrenal 
insufficiency related to the use of corticosteroids, no study 
Fig. 1 − Meta-analysis on the efficacy of dexamethasone in the prophylaxis of postoperative complications in patients 
submitted to laparoscopic cholecystectomy. 95% CI, 95% confidence interval; F, female; M, male.
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reported an increase in the risk of adverse effects. Additionally, 
the use of dexamethasone is known to prevent the sedative, 
dysphoric, and extrapyramidal effects related to traditional 
drugs such as droperidol and metoclopramide.
Data obtained in this review may reinforce the idea of 
performing laparoscopic cholecystectomy as an ambulatory 
procedure, resulting in lower hospital costs, reduction in 
surgery waiting times, and less discomfort for the patient. 
Thus, surgeons and anesthetists should contemplate the 
prophylactic use of dexamethasone in patients submitted to 
laparoscopic cholecystectomy, especially in those more prone 
to nausea and vomiting.
Conclusion
The preoperative infusion of 8 mg of dexamethasone decreased 
the risk of complications in the postoperative period for 
patients submitted to laparoscopic cholecystectomy. 
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